Wenfeng Gong

发表

The binding of an anti-PD-1 antibody to FcγRΙ has a profound impact on its biological functions

Xiaomin Song, Tong Zhang, Xiaolong Yang, 2018, Cancer Immunology, Immunotherapy.

Effects of Nickel on Cyclin Expression, Cell Cycle Progression and Cell Proliferation in Human Pulmonary Cells

Hongyang Wang, Chuanshu Huang, Kun Wu, 2009, Cancer Epidemiology Biomarkers & Prevention.

699 A differentiated anti-OX40 agonist BGB-A445 does not block OX40-OX40L interaction and reveals remarkable anti-tumor efficacy in preclinical models

X. Liu, Xiaomin Song, Tong Zhang, 2020, Journal for ImmunoTherapy of Cancer.

Astragaloside IV Exerts Antiviral Effects Against Coxsackievirus B3 by Upregulating Interferon-γ

Y. Huang, Chenggang Huang, Wenfeng Gong, 2006, Journal of cardiovascular pharmacology.

Contribution of a WRKY Transcription Factor, ShWRKY81, to Powdery Mildew Resistance in Wild Tomato

Wenfeng Gong, Yang Wang, Han Wang, 2023, International journal of molecular sciences.

IDO1 Inhibition Synergizes with Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced Glioblastoma

C. James, R. Stupp, D. Scholtens, 2018, Clinical Cancer Research.

Suppression of cyclin D1 by hypoxia-inducible factor-1 via direct mechanism inhibits the proliferation and 5-fluorouracil-induced apoptosis of A549 cells.

Jin Ding, Lei Chen, Kun Wu, 2010, Cancer research.

BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in BRAF-Mutated Colorectal Cancers

J. Ji, Xiaoxiao Hu, S. Cheung, 2015, Molecular Cancer Therapeutics.

Abstract 1651: BGB-290, a novel PARP inhibitor with unique brain penetration ability, demonstrated strong synergism with temozolomide in subcutaneous and intracranial xenograft models

B. Jiang, Zhe Shi, L. Luo, 2015 .

Pamiparib is a potent and selective PARP inhibitor with unique potential for the treatment of brain tumor

X. Liu, Xiaomin Song, Zhirong Shen, 2020, Neoplasia.

Discovery of Pamiparib (BGB-290), a Potent and Selective Poly (ADP-ribose) Polymerase (PARP) Inhibitor in Clinical Development.

Zhiwei Wang, X. Liu, L. Luo, 2020, Journal of medicinal chemistry.

Cyclin D1 Induction by Benzo[a]pyrene-7,8-diol-9,10-epoxide via the Phosphatidylinositol 3-Kinase/Akt/MAPK- and p70s6k-dependent Pathway Promotes Cell Transformation and Tumorigenesis*

G. Cao, Hongyang Wang, Kun Wu, 2009, The Journal of Biological Chemistry.

TNF-α Induction by Nickel Compounds is Specific Through ERKs/AP-1- Dependent Pathway in Human Bronchial Epithelial Cells

Hongyang Wang, Jingxia Li, Chuanshu Huang, 2009 .

TNF-alpha induction by nickel compounds is specific through ERKs/AP-1-dependent pathway in human bronchial epithelial cells.

Hongyang Wang, Jingxia Li, Chuanshu Huang, 2009, Current cancer drug targets.

RAF dimer inhibition enhances the antitumor activity of MEK inhibitors in K‐RAS mutant tumors

N. Rosen, Paul D. Smith, Xiaoxiao Hu, 2020, Molecular oncology.

Abstract 1653: BGB-290: A highly potent and specific PARP1/2 inhibitor potentiates anti-tumor activity of chemotherapeutics in patient biopsy derived SCLC models

B. Jiang, Zhe Shi, Jun Zhao, 2015 .

Suppression of cyclin D1 by hypoxia-inducible factor-1 via direct mechanism inhibits the proliferation and 5-fluorouracil-induced apoptosis of A549 cells.

Hongyang Wang, Kun Wu, Jin Ding, 2010, Cancer research.

Discovery of Pamiparib (BGB-290), a Potent and Selective Poly (ADP-ribose) Polymerase (PARP) Inhibitor in Clinical Development.

Zhiwei Wang, X. Liu, L. Luo, 2020, Journal of medicinal chemistry.